WallStreetZenWallStreetZen

NASDAQ: LBPH
Longboard Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LBPH

Based on 5 analysts offering 12 month price targets for Longboard Pharmaceuticals Inc.
Min Forecast
$32.00+57.87%
Avg Forecast
$44.80+121.02%
Max Forecast
$60.00+196%

Should I buy or sell LBPH stock?

Based on 5 analysts offering ratings for Longboard Pharmaceuticals Inc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LBPH stock forecasts and price targets.

LBPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-16
lockedlocked$00.00+00.00%2024-04-10
lockedlocked$00.00+00.00%2024-03-13
lockedlocked$00.00+00.00%2024-02-16
lockedlocked$00.00+00.00%2024-01-02Find Out Why

1 of 1

Forecast return on equity

Is LBPH forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is LBPH forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LBPH revenue forecast

What is LBPH's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.9M
Avg 2 year Forecast
$20.7M
Avg 3 year Forecast
$79.4M

LBPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LBPH$20.27$44.80+121.02%Strong Buy
PRTC$26.15N/AN/A
AUPH$5.09$10.33+103.01%Strong Buy
COGT$6.96$13.67+96.36%Buy
ELVN$17.37$34.00+95.74%Strong Buy
View Top Biotech Stocks

Longboard Pharmaceuticals Stock Forecast FAQ

Is Longboard Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: LBPH) stock is to Strong Buy LBPH stock.

Out of 5 analysts, 3 (60%) are recommending LBPH as a Strong Buy, 2 (40%) are recommending LBPH as a Buy, 0 (0%) are recommending LBPH as a Hold, 0 (0%) are recommending LBPH as a Sell, and 0 (0%) are recommending LBPH as a Strong Sell.

If you're new to stock investing, here's how to buy Longboard Pharmaceuticals stock.

What is LBPH's revenue growth forecast for 2025-2027?

(NASDAQ: LBPH) Longboard Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Longboard Pharmaceuticals's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast LBPH's revenue for 2025 to be $464,622,512, with the lowest LBPH revenue forecast at $464,622,512, and the highest LBPH revenue forecast at $464,622,512. On average, 1 Wall Street analysts forecast LBPH's revenue for 2026 to be $745,557,054, with the lowest LBPH revenue forecast at $745,557,054, and the highest LBPH revenue forecast at $745,557,054.

In 2027, LBPH is forecast to generate $2,859,769,571 in revenue, with the lowest revenue forecast at $2,337,519,460 and the highest revenue forecast at $3,382,019,681.

What is LBPH's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LBPH) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LBPH's Price Target?

According to 5 Wall Street analysts that have issued a 1 year LBPH price target, the average LBPH price target is $44.80, with the highest LBPH stock price forecast at $60.00 and the lowest LBPH stock price forecast at $32.00.

On average, Wall Street analysts predict that Longboard Pharmaceuticals's share price could reach $44.80 by Apr 16, 2025. The average Longboard Pharmaceuticals stock price prediction forecasts a potential upside of 121.02% from the current LBPH share price of $20.27.

What is LBPH's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LBPH) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.